Reed Elsevier NV AGM 23 April 2014

AMSTERDAM--()--Regulatory News:

For immediate release
23 April 2014

Reed Elsevier NV announces that the Annual General Meeting of Shareholders (AGM), held in Amsterdam on 23 April, approved the 2013 financial statements and determined the total dividend for 2013 at € 0,506 per ordinary share of € 0,07 nominal value. After taking account of the interim dividend paid in August 2013 of € 0,132 per ordinary share the final dividend is € 0,374 per ordinary share.

All resolutions were approved by the AGM. These include: the appointment of Mr Nick Luff as an executive director, the re-appointment of Erik Engstrom and Duncan Palmer as executive directors and the re-appointment of all non-executive directors.

The results of the voting on each resolution are set out below:

                                   
 
Resolution For % Against % Votes withheld
 
4. Adoption of the 2013 483,603,989 99.99% 55,872 0.01% 1,842,862
Annual Financial Statements
5.a Release from liability of 472,029,219 97.78% 10,704,413 2.22% 2,769,559
executive directors
5.b Release from liability of 472,029,413 97.78% 10,704,219 2.22% 2,769,559
non-executive directors
6. Determination and 481,861,583 99.62% 1,857,632 0.38% 1,783,776
distribution of dividend
7. Appointment of external 473,084,712 98.08% 9,267,742 1.92% 3,150,736
auditors
8. (i) Appointment of Nick 481,844,918

99.62%

1,859,860

0.38%

1,796,863

Luff; and (ii) an award of
shares in the Company

481,844,636

99.62%

1,860,791

0.38%

1,797,764

 
 
9a. Re-appointment 479,568,259 99.14% 4,140,572 0.86% 1,794,360
Anthony Habgood
9b. Re-appointment of 482,383,859 99.73% 1,324,857 0.27% 1,794,474
Wolfhart Hauser
9c. Re-appointment Adrian 481,916,634 99.63% 1,792,079 0.38% 1,794,477
Hennah
9d. Re-appointment Lisa 483,682,993 99.99% 33,081 0.01% 1,787,117
Hook
9e. Re-appointment Marike 481,948,903 99.63% 1,766,776 0.38% 1,787,512
van Lier Lels
9f. Re-appointment Robert 481,901,339 99.62% 1,814,617 0.38% 1,787,235
Polet
9g. Re-appointment Linda 481,922,233 99.63% 1,793,729 0.38% 1,787,229
Sanford
9h. Re-appointment Ben van 476,806,264 99.76% 1,160,953 0.24% 7,535,974
der Veer
10a. Re-appointment Erik 483,678,641 99.99% 37,029 0.01% 1,787,519
Engstrom
10b. Re-appointment 483,019,986 99.86% 688,731 0.14% 1,794,474
Duncan Palmer
 
11. Delegation to the Board 481,656,752 99.89% 528,700 0.11% 3,317,739
of the authority to acquire
shares in the Company

12a. Designation of the
Board as authorised body to

397,512,711 82.19% 86,148,484 17.81% 1,841,996
issue shares and to grant
rights to acquire shares in
the capital of the Company
12b. Extension of the 391,586,481 80.96% 92,074,041 19.04% 1,842,669
designation of the Board as
authorised body to limit or
exclude pre-emptive rights
to the issuance of shares

Note:

Votes ‘withheld’ are not counted in the calculation of the proportion of votes ‘for’ or ‘against’ a resolution.

-ENDS-

Issued on behalf of Reed Elsevier NV

Contacts

Reed Elsevier
Enquiries Paul Abrahams (Media)
Tel: +44 20 7166 5724
or
Colin Tennant (Investors)
Tel: +44 20 7166 5751

Sharing

Contacts

Reed Elsevier
Enquiries Paul Abrahams (Media)
Tel: +44 20 7166 5724
or
Colin Tennant (Investors)
Tel: +44 20 7166 5751